Abstract
Background: The administration of many pharmaceutical active ingredients is often performed by the injection of an aqueous-based solution. Numerous active ingredients are however, insoluble in water, which complicates their administration and restricts their efficacy.
Objective: The current solutions are hindered by both, a time-consuming manufacturing process and unsuitability for hydrophilic and hydrophobic materials. Methods: Emulsions of oleophilic active ingredients and polyprotein microspheres are an important step to overcome insolubility issues. Results: Polyprotein microspheres offer a versatile modifiable morphology, thermal responsivity, and size variation, which allows for the protection and release of assembled biomaterials. In addition, nanospheres present promising cell phagocytosis outcomes in vivo. Conclusion: In this research, a reproducible multifunctional approach, to assemble nanospheres in one step, using a technique termed “automatic nanoscalar interfacial alternation in emulsion” (ANIAE) was developed, incorporating a thermally controlled release mechanism for the assembled target active ingredients. These results demonstrate a viable, universal, multifunctional principal for the pharmaceutical industry.Keywords: Self-Assembly, oleophilic nanospheres, polyprotein, ANIAE, thermally controlled release, assembled biomaterials.
Graphical Abstract
[http://dx.doi.org/10.1021/la101246a] [PMID: 20459072]
[http://dx.doi.org/10.1038/s41467-017-01420-8] [PMID: 29118327]
[http://dx.doi.org/10.1517/17425247.2016.1162154] [PMID: 26984045]
[http://dx.doi.org/10.1016/j.tifs.2019.02.030]
[http://dx.doi.org/10.1097/TA.0000000000001615] [PMID: 28598907]
[http://dx.doi.org/10.1016/j.ejps.2007.03.005] [PMID: 17462869]
[http://dx.doi.org/10.1016/j.ijpharm.2018.06.009] [PMID: 29883791]
[http://dx.doi.org/10.1136/vr.160.11.374] [PMID: 17369479]
[http://dx.doi.org/10.1016/0013-4694(70)90202-6] [PMID: 4192836]
[http://dx.doi.org/10.1111/j.1468-2982.2008.01800.x] [PMID: 19250287]
[http://dx.doi.org/10.1111/vop.12440] [PMID: 27981712]
[http://dx.doi.org/10.1021/jf9013263] [PMID: 19722585]
[http://dx.doi.org/10.1007/s00394-007-1001-z] [PMID: 17665093]
[http://dx.doi.org/10.1002/ijc.25008] [PMID: 19876916]
[http://dx.doi.org/10.1039/c3cs60030k] [PMID: 23571407]
[http://dx.doi.org/10.1021/la971271z]
[http://dx.doi.org/10.1021/nl061604p] [PMID: 17034091]
[http://dx.doi.org/10.1007/s12393-015-9108-0]
[http://dx.doi.org/10.1016/j.carbpol.2011.01.015]
[http://dx.doi.org/10.1038/pj.2013.86]
[http://dx.doi.org/10.1038/ncomms10447] [PMID: 26794442]
[http://dx.doi.org/10.1016/j.ijpharm.2005.04.029] [PMID: 15951143]
[http://dx.doi.org/10.1016/j.tibtech.2006.12.007] [PMID: 17207546]
[http://dx.doi.org/10.1021/nn8002168] [PMID: 19206419]
[http://dx.doi.org/10.1016/j.jfoodeng.2009.06.034]
[http://dx.doi.org/10.1016/j.molimm.2012.05.011] [PMID: 22677715]
[http://dx.doi.org/10.1016/j.supflu.2010.12.013]
[http://dx.doi.org/10.1038/s41570-018-0042-6]
[http://dx.doi.org/10.1002/smll.200600613] [PMID: 17340665]
[http://dx.doi.org/10.1038/s41467-018-04320-7] [PMID: 29765045]
[http://dx.doi.org/10.1039/C3PY00942D]
[http://dx.doi.org/10.1038/s41598-017-03259-x] [PMID: 28596597]
[http://dx.doi.org/10.1021/jf504673v] [PMID: 25560778]
[http://dx.doi.org/10.1039/a806626d]
[http://dx.doi.org/10.1016/j.cis.2016.03.002] [PMID: 27181392]
[http://dx.doi.org/10.1016/j.memsci.2011.12.009]
[http://dx.doi.org/10.1038/s41428-018-0025-y]
[http://dx.doi.org/10.1038/nnano.2008.188] [PMID: 18685640]